BiotechTube
Home/Vaderis Therapeutics/Tom Harris
TH

Tom Harris

Chief Operating & Development Officer

Vaderis Therapeutics

Therapeutic Areas

Rare Vascular DiseasesHereditary Hemorrhagic Telangiectasia (HHT)

Vaderis Therapeutics Pipeline

DrugIndicationPhase
EngasertibHereditary Hemorrhagic Telangiectasia (HHT)Pre-clinical

Leadership Team at Vaderis Therapeutics

AN
Azmi Nabulsi, MD, MPH
President & CEO
DP
Damien Picard, MD, PhD
Senior Medical Director & Co-Founder
PS
Pierre Saint-Mezard, PhD, MBA
Chief Scientific Officer & Co-Founder
DS
Darryl Sleep, MD
Chief Medical Officer
View full Vaderis Therapeutics profile